Final Safety Results of a Phase 1 Clinical Trial of Afatinib in Combination With Docetaxel and Postoperative Radiation Therapy for High-Risk Squamous Cell Carcinoma of the Head and Neck
International Journal of Radiation Oncology Biology Physics - Netherlands
doi 10.1016/j.ijrobp.2017.12.052
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2018
Authors
Publisher
Elsevier BV